Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Mayne Pharma Group (AU:MYX)
ASX:MYX
RESEARCH TOOLSreports
Mayne Pharma Group (MYX) Share Price & Analysis
9 Followers
MYX Stock Chart & Stats
Day’s RangeAU$0 - AU$0
52-Week RangeAU$2.75 - AU$7.40
Previous CloseAU$6.8
Volume12.37K
Average Volume (3M)213.46K
Market Cap
AU$592.12M
Enterprise ValueAU$901.46M
Total Cash (Recent Filing)AU$96.67M
Total Debt (Recent Filing)AU$413.67M
Price to Earnings (P/E)-2.3
Beta0.88
Next Earnings
Aug 23, 2024EPS Estimate
-AU$0.16Last Dividend Ex-Date
Jan 18, 2023Dividend YieldN/A
Share Statistics
EPS (TTM)-2.93
Shares OutstandingN/A
10 Day Avg. Volume208,972
30 Day Avg. Volume213,458
Standard Deviation0.13
R-Squared0.10
Alpha-0.02
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
AU$7.03Price Target Upside5.52% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
Mayne Pharma Group News
MYX FAQ
What was Mayne Pharma Group’s price range in the past 12 months?
Mayne Pharma Group lowest share price was AU$2.75 and its highest was AU$7.40 in the past 12 months.
What is Mayne Pharma Group’s market cap?
Currently, no data Available
When is Mayne Pharma Group’s upcoming earnings report date?
Mayne Pharma Group’s upcoming earnings report date is Aug 23, 2024 which is in 119 days.
How were Mayne Pharma Group’s earnings last quarter?
Mayne Pharma Group released its earnings results on Feb 25, 2024. The company reported -AU$0.878 earnings per share for the quarter, missing the consensus estimate of -AU$0.46 by -AU$0.418.
Is Mayne Pharma Group overvalued?
According to Wall Street analysts Mayne Pharma Group’s price is currently Undervalued.
Does Mayne Pharma Group pay dividends?
Mayne Pharma Group pays a Notavailable dividend of AU$0.03 which represents an annual dividend yield of N/A. See more information on Mayne Pharma Group dividends here
What is Mayne Pharma Group’s EPS estimate?
Mayne Pharma Group’s EPS estimate is -AU$0.16.
How many shares outstanding does Mayne Pharma Group have?
Mayne Pharma Group has 85,074,290 shares outstanding.
What happened to Mayne Pharma Group’s price movement after its last earnings report?
Mayne Pharma Group reported an EPS of -AU$0.878 in its last earnings report, missing expectations of -AU$0.46. Following the earnings report the stock price went down -22.737%.
Which hedge fund is a major shareholder of Mayne Pharma Group?
Currently, no hedge funds are holding shares in AU:MYX
---
Mayne Pharma Group Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
AU$7.03 (5.52% Upside)
AU$7.03 (5.52% Upside)
Blogger Sentiment
Bullish
AU:MYX Sentiment 88%
Sector Average 70%
Sector Average 70%
Technicals
SMA
Positive
20 days / 200 days
Momentum
59.63%
12-Months-Change
Fundamentals
Return on Equity
-37.86%
Trailing 12-Months
Asset Growth
-22.29%
Trailing 12-Months
Company Description
Mayne Pharma Group
Mayne Pharma Group Ltd. engages in the development and manufacture of proprietary and generic products. It operates through the following segments: Generic Products, Specialty Brands, Metrics Contract Services, and Mayne Pharma International. The Generic Products segment involves in the manufacture and distribution of generic and branded pharmaceutical products. The Metrics Contract Services segment provides contract pharmaceutical services. The Specialty brands segments includes the distribution of branded pharmaceutical products. The Mayne Pharma International segment offers manufacturing and selling of branded and generic pharmaceutical products and provides contract manufacturing services to third party customers within Australia. The company was founded in 1845 and is headquartered in Salisbury, Australia.
---
MYX Stock 12 Months Forecast
Average Price Target
AU$7.03
▲(5.52% Upside)
Technical Analysis
Mayne Pharma Group
―
Amneal Pharmaceuticals
―
Heron Therapeutics
―
Teva Pharmaceutical
―
Acasti Pharma
―
Best Analysts Covering MYX
1 Year
1 Year Success Rate
5/9 ratings generated profit
1 Year Average Return
-5.78%
upgraded a buy rating 2 months ago
Copying Melissa Benson's trades and holding each position for 1 Year would result in 55.56% of your transactions generating a profit, with an average return of -5.78% per trade.
---